Study Design. A retrospective study of a consecutive series of all patients with pyogenic spinal infections treated at a single institution over a 10-year period.
Pyogenic spinal infections (PSIs) are uncommon, representing only 2% to 7% of all skeletal infections. 1, 2 In the past, spinal infections had been devastating conditions, which, if untreated, often led to neurologic involvement, deformity, chronic pain, or death. Mortality rates with spinal infections in the preantibiotic era were between 25% to 75%. 3, 4 Though this grim prognosis has improved since the advent of antibiotics, 5-10 the incidence and complexity of spinal infections has paradoxically increased. These trends are likely secondary to a number of factors, including a change in the epidemiological characteristics of affected patients (e.g., rising prevalence of immunocompromise), rapidly increasing numbers of invasive spinal procedures, the emergence of drugresistant microorganisms, and the presence of complex comorbidities. [5] [6] [7] [8] [9] [10] PSI's are frequently associated with neurologic deficit at the time of initial diagnosis, with reported incidences range from 29% to 51%. 8, 11 A few studies have delineated identifiable risk factors for neurologic involvement with PSI. 5, 11, 12 Current evidence suggests that advanced age, diabetes mellitus, rheumatoid arthritis, systemic corticosteroid therapy, impaired immune status, infection with Staphylococcus aureus, and more proximal involvement infection impose a higher risk for neurologic involvement. 5, 11, 12 Though chronic liver failure (CLF) has been associated with a higher risk for PSI, 13 it has not been previously identified as a risk factor for neurologic involvement. 14, 15 Based on experience with a large population of CLF patients, it has been the authors' impression that this condition is associated with a higher than usual rate of neurologic deficit. To investigate this possible correlation, the authors performed a retrospective analysis of a consecutive series of patients with PSI at a single institution, hypothesizing that, among other variables, CLF was a risk factor for neurologic deficit at presentation. The authors postulated that the frequent presence of a concomitant nonspinal infection in this subgroup could draw attention from and delay the diagnosis of a spinal infection. The authors additionally postulated that CLF patients could represent a group of PSI patients with comparably more severe systemic disease that may predispose to neurologic decline.
Materials and Methods
A review of all patients admitted to a single institution who were discharged with a diagnosis of a PSI between January diagnoses of vertebral osteomyelitis, disc space infection (i.e., pyogenic discitis), epidural abscess, and septic facet arthritis. Inclusion criteria were (1) presence of a hematogenous, pyogenic spinal column infection (i.e., not the result of direct inoculation) and (2) evidence of spinal column involvement on conventional radiographs, computed tomography, or magnetic resonance imaging. The former (pyogenic infection) needed to be confirmed by either (1) microbiological identification of a microorganism isolated from the affected vertebral bone, intervertebral disc space, paravertebral or epidural abscesses, or facet fluid, (2) two or more positive blood cultures in a patient with clinical and radiologic signs and symptoms of a PSI, or (3) unequivocal clinical signs and symptoms of a PSI with concordant evidence of spinal involvement on magnetic resonance imaging in a patient with negative local and blood cultures. Patients with granulomatous, fungal, and postsurgical infections and those related to decubitus ulcers were excluded from the study.
Various clinical and radiographic data were collected. This included age, sex, site of infection, degree of neurologic impairment, and bacterial organism isolated. Neurologic impairment was defined as any motor or sensory deficit from either spinal cord or nerve root dysfunction and categorized as complete (no motor or sensory function below the level of the lesion) or partial (some motor or sensory function below the level of the lesion). The presence of various medical comorbidities and pertinent social data were recorded, including diabetes mellitus, rheumatoid arthritis, chronic corticosteroid therapy, chronic liver failure (CLF), chronic renal failure, smoking, human immunodeficiency virus (HIV) infection, intravenous drug abuse, cancer, cardiac disease, and the presence of a known distant, nonspinal site of infection. Laboratory results at the time of presentation were also recorded; they included hematocrit, white blood cell count, erythrocyte sedimentation rate, C-reactive protein, and serum creatinine.
For each covariable, the number of detected cases and its frequency or mean plus or minus standard deviation were calculated. Statistical comparisons were made between the groups with and without neurologic impairment using the MannWhitney U test for continuous variables and a 2 or Fisher exact test for categorical variables. A P value less than 0.05 was considered to be statistically significant. Relative risk analyses were performed for each of the covariables suspected to be a risk for development of a neurologic deficit. These data were reported as relative risk (RR) values with corresponding 95% confidence intervals (CIs).
Results
A total of 55 consecutive patients with pyogenic spinal infections satisfied the inclusion criteria (Table 1 ). There were 32 men and 23 women with an average age of 64.4 years. Of note, 84% of the patients were 50 years of age or older. A large majority of the patients had vertebral osteomyelitis with or without adjacent discitis (47/55, 85%). Twenty-one of these patients had an epidural abscess that occurred secondarily. The next most common subdiagnosis was primary epidural abscess (6 of 55, 11%). There was 1 patient each with isolated discitis and septic facet arthritis.
The site of infection varied. Lumbar infections were most common (35 of 55, 64%), followed by cervical (12 of 55, 22%) and thoracic infections (7 of 55, 13%). One patient had multifocal PSI with involvement of the cervical, thoracic, and lumbar regions.
Twenty-four of the 55 patients (44%) had a neurologic deficit at the time of presentation. Of these 24 patients, only 1 had a complete deficit. Twenty-three patients had a partial deficit, 16 of which were localized to a radicular distribution. Seven patients had frank tetraparesis or paraparesis.
A number of organisms were responsible for the infections. The most common bacteria was S. aureus (23 patients, 42.8%). Of these, 4 were multidrug resistant. Streptococci, coagulase-negative Staphylococcus, Escherichia coli, Enterococcus, Salmonella, Enterobacter, and Eikenella corrodens were identified in 5 cases, 4 cases, 2 cases, 2 cases, 1 case, and 1 case, respectively. No organism was identified in 9 patients; 7 of these patients had received antibiotics the days before cultures were obtained. The reason for antibiotic administration was the presence of an extraspinal infection (5 cases), or they received antibiotics empirically while febrile, before the spinal infection was diagnosed (2 cases).
Infection site or blood cultures were attempted in all patients. Blood cultures were obtained in 50 patients, though they were positive in only 26 (52%) patients. Percutaneous, fluoroscopically, or CT-guided aspirations of an intervertebral disc space, vertebra, or para- One patient had 2 sites of nonspine infection. Types of nonspine infection included urinary tract infections (8 cases), pneumonia (4 cases), infectious endocarditis (4 cases), infected central venous catheter (3 cases), bacteremia and/or septic shock (3 cases), nonspine musculoskeletal abscess (2 cases), nonspine septic arthritis, infectious celulitis (1 case), meningitis (1 case), and infectious cholangitis (1 case).
One or more comorbidity was present in 42 of 55 patients (76.4%). Comparing those with and without neurologic deficits at presentation, there was no statistically significant difference in the incidence of any comorbidity except for CLF. There was a 33.3% rate of CLF in those with neurologic involvement versus a 6.5% rate in those without neurologic involvement (P ϭ 0.01) ( Table 2) .
In examining a number of key infection related covariables, the authors detected a statistically higher rate (P ϭ 0.021) of distant nonspine infection in the neurologically impaired group (66.7%) compared with the neurologically intact group (35.5%) (Table 3) . Predictably, epidural abscess were also much more common in the neurologically impaired group (79.2% vs. 8%, P ϭ 0.0001). There were no detectable differences in the rates of cervical involvement or S. aureus infections between the 2 groups.
In analysis of laboratory values, the average white blood cell count was statistically higher in patients with neurologic impairment than those without (Table 4) . Hematocrit, erythrocyte sedimentation rate, C-reactive protein, blood urea nitrogen, and blood creatinine showed not statistical differences.
Relative risk analysis showed that patients with an epidural abscess had the greatest risk for a neurologic deficit (RR ϭ 3.94, 95% CI ϭ 1.905-8.626). However, the next most influential factors were the presence of CLF (RR ϭ 2.25, 95% CI ϭ 1.246 -2.905) and concomitant nonspine infection (RR ϭ 2.07, 95% CI ϭ 1.108 -3.958). Concerning laboratory values, an elevated white blood cell count greater than or equal to 11,000 cells/ mm 3 (defined as abnormal by the institution's laboratory) had an RR of 1.66 (95% CI ϭ 0.892-3.253), which was not considered statistically significant.
Discussion
Before this study, the authors had an a priori suspicion that CLF was associated with a higher than usual rate of neurologic impairment in patients with pyogenic spinal infections. The current data seems to confirm this suspicion. In addition, the authors found that the presence of a concomitant distant, nonspine infection was associated with a higher rate of neurologic deficit at presentation. To the authors' knowledge, these 2 risk factors have not been previously reported. In agreement with previous The authors have postulated an explanation of why CLF would be a risk factor for neural deficit with PSI. First, those with CLF can be substantially medically compromised. Supporting this, previous work has indicated that CLF is a general risk factor for infection. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Overall, the most common infections are spontaneous bacterial peritonitis (44%), urinary tract infections (25%), pneumonia (15%), and bacteremia (5%). A common pathway of infection is thought to be from compromise of the gastrointestinal barrier from secondary changes in the intestinal flora, which allows spontaneous translocation of bacteria. In addition, disruption of the skin and mucous barriers from the high rate of invasive procedures required in these patients (e.g., central venous catheter, endotracheal intubation, urinary catheter) magnified by decreased neutrophil and reticuloendothelial function and diminished complement and immunoglobulin levels. Compromise of these defenses allows activation of endothelial cells that express a variety of surface receptors that permit increased adhesion of bacteria. 14,15,24 -30 Finally, malnutrition, commonly present with CLF, is a well-known risk factor for infection. As patients with CLF may be more medically compromised than those without CLF, the rapidity with which infection proceeds may be greater. This might lead to a greater number of patients developing epidural abscess and a neurological deficit over a short hospital course.
The presence of a concomitant, distant site of infection at the time of PSI diagnosis was also identified as a risk factor for neurologic impairment. In agreement with the above discussion, this could simply be a reflection of patients' overall poor medical status. However, the authors additionally speculate that the presence of a nonspine infection can detract attention and thus delay diagnosis of spinal infection. As delay in diagnosis can increase the risk for neurologic impairment, 31 these data highlight the importance of maintaining a high-level of suspicion for spinal infection in patients with nonspinal infection.
What is unclear from this study is whether the spine infection was primary and the distant site infection secondary, or vice versa. Further study to identify clinical features that may prompt more aggressive spinal imaging in patients with nonspine infections is needed. It is interesting, however, that the proportion of nonspinal infection was similar in patients with CLF and the entire group (50% and 49.1%, respectively). This suggests that the frequency of nonspinal infection in patients with PSI is not increased by the presence of CLF.
It is important to compare the current data to previous studies that have reported risk factors for neurologic impairment associated with PSI. In a retrospective review of 111 patients with pyogenic vertebral osteomyelitis, Carragee 5 found that S. aureus infection, impaired immune status, and thoracic involvement were associated with greater degrees of neurologic loss. In contrast, the current study did not find S. aureus or thoracic involvement to be risk factors. This could have been the result of studying a different patient population or ␤-error (type II), as Carragee's study had over twice as many patients.
In a review of 61 patients with vertebral osteomyelitis, Eismont et al 11 found age over 50 years old, diabetes mellitus, rheumatoid arthritis, systemic corticosteroid therapy, cervical involvement, and S. aureus were risk factors for neural deficit. In a follow-up study of 253 patients with vertebral osteomyelitis (which included those from Eismont et al 11 ) , McHenry et al 32 again found that cervical spine infections, diabetes mellitus, and age over 50 years were risk factors for paralysis. In the present study, these risk factors were not corroborated. As indicated above, this is potentially explained by the differences in patient populations; in a similar way, as we present a smaller series, a ␤-error could also explain the differences in risk factors compared with other series.
One salient example of population differences is the fact that there was only 1 person in the current study who was receiving systemic corticosteroid therapy. Therefore, it is more accurate to conclude that there was insufficient data that corticosteroid therapy was not a risk factor. Similarly, as 83.6% of patients in the current study were older than 50 years, age could not be adequately compared in the 2 groups. In contrast, there were comparable numbers (8 and 6 patients, respectively) of those with diabetes mellitus in the neurologically and non-neurologically impaired groups in the current study. Although diabetes stands as a general risk factor for spinal infection, it may not be as strong a risk factor for neural deficit as previously suggested. There are risk factors that have been previously identified that were not assessed in the current study. Khanna et al 21 assessed outcome predictors in a review of 41 cases of spinal epidural abscess. With univariate analysis, they found patient age, degree of thecal sac compression, infection region, surgical findings, and septic presentation were significantly associated with outcome. With multivariate analysis, only age and degree of thecal sac compression affected outcome. It is difficult to compare these findings with the current study, as most patients in the current study were over 50 years old and the degree of thecal sac compression was not measured.
Conclusion
The current study suggests that CLF and the presence of a distant nonspine infection are risk factors for neurologic involvement in patients with PSI. To the authors' knowledge, these risk factors have not been previously described. As neurologic injury can have devastating consequences, these data may help raise suspicion for spinal infection in these groups.
Key Points
• Pyogenic spinal infections are frequently associated with neurologic deficit at diagnosis.
• Current evidence suggests that advanced age, diabetes mellitus, rheumatoid arthritis, systemic corticosteroid therapy, impaired immune status, infection with S. aureus, and more proximal infections are risk factors for neurologic involvement.
• Our results suggest that chronic liver failure and the presence of a distant nonspine infection are risk factors for neurologic involvement in patients with pyogenic spinal infections.
